Invadopodia-Mediated Remodeling of the Lymphatic Endothelium Drives Cancer Cell Lymphatic Dissemination and is Regulated by a CCR7-Vav2-Rac3 Signaling axis.

Abstract

Cancer cell invasion across a lymphatic endothelial barrier and subsequent colonization of regional lymph nodes often marks the first stage of metastatic dissemination. Lymphatic vessels facilitate the escape of cancer cells and can support further metastatic dissemination. Although the clinical and experimental evidence supports a role for lymph node metastases in promoting metastatic spread, the mechanism employed by cancer cells to navigate a lymphatic endothelium and enter lymphatic vessels is poorly characterized. To investigate this, we assessed the interactions between cancer cells and lymphatic endothelial cells and found that Tks5-positive structures, termed invadopodia, remodel lymphatic endothelial junctions. Loss of Tks5 impaired cancer cell invasion across a lymphatic endothelium and significantly reduced lymph node and lung metastasis in a mouse model of breast cancer progression. Surgical removal of the axillary and brachial lymph nodes prior to orthotopic cancer cell injection resulted in a significant reduction in lung tumor burden, further demonstrating the significance of lymph node metastases to metastatic tumor burden. Next, using breast cancer patient primary tumors we found that elevated expression of CCR7, a chemokine receptor, significantly associated with lymph node metastasis. CCR7 localized to invadopodia and promoted cancer cell invasion across lymphatic endothelium, both in the presence and absence of its canonical ligand CCL19. Tyrosine phosphorylation of CCR7 directed the recruitment of Vav2 and activation of Rac3. Our findings highlight a role for lymphatic metastases in promoting distant metastasis and establish a mechanism by which cancer cells breach a lymphatic endothelium.